Investigation
Inari Medical, Inc. (NARI)
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Menu
Investigation
11/10/2021
Initial Lawsuit
12/22/2021
Lawsuit Progression
04/15/2022
This is a federal securities class action on behalf of a class consisting of all persons and entities other than defendants who purchased or otherwise acquired common shares of Arrival stock between November 18, 2020 and November 19, 2021, both dates inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(i) the company would record a substantially greater net loss and adjusted EBITDA loss in the third quarter of 2021compared to the third quarter of 2020;
(ii) the company would experience far greater capital and operational expense to operate and deploy its microfactories and manufacture EV vehicles than it had disclosed;
(iii) the company would not capitalize on or achieve profitability or provide meaningful revenue in the time periods disclosed;
(iv) the company would not achieve its disclosed production and sales volumes;
(v) the company would not meet the disclosed production rollout deadlines;
(vi) accordingly, the company materially overstated its financial and operational position and/or prospects; and
(vii) as a result, the company’s public statements were materially false and misleading at all relevant times.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.